Oral or Parenteral Methotrexate for the Treatment of Polyarticular Juvenile Idiopathic Arthritis
暂无分享,去创建一个
[1] A. Ravelli,et al. Juvenile Idiopathic Arthritis: Diagnosis and Treatment , 2016, Rheumatology and Therapy.
[2] P. Doležalová,et al. Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration , 2016, Pediatric Rheumatology.
[3] M. Islam,et al. Comparative efficacy of subcutaneous versus oral methotrexate in active rheumatoid arthritis. , 2013, Mymensingh medical journal : MMJ.
[4] I. Foeldvari,et al. Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: An observational study with patients from the German Methotrexate Registry , 2012, Arthritis care & research.
[5] A. Martini,et al. Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score. , 2012, Arthritis and rheumatism.
[6] Bin Huang,et al. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis , 2011, Arthritis care & research.
[7] A. Dirican,et al. Do infections trigger juvenile idiopathic arthritis? , 2011, Rheumatology International.
[8] R. Burgos-Vargas,et al. The use of methotrexate in children with rheumatic diseases. , 2010, Clinical and experimental rheumatology.
[9] Alberto Martini,et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. , 2009, Arthritis and rheumatism.
[10] I. Foeldvari,et al. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry , 2008, Annals of the rheumatic diseases.
[11] R. Saurenmann,et al. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. , 2004, Arthritis and rheumatism.
[12] M. Suarez‐Almazor,et al. International League of Associations for Rheumatology: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001 , 2004 .
[13] A. Martini,et al. Methotrexate in juvenile idiopathic arthritis: answers and questions. , 2000, The Journal of rheumatology.
[14] C. Doré,et al. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. , 2000, Arthritis and rheumatism.
[15] A. Martini,et al. The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis. , 1999, The Journal of pediatrics.
[16] C. Wallace,et al. The use of methotrexate in childhood rheumatic diseases. , 1998, Arthritis and rheumatism.
[17] A. Martini,et al. Oral versus intramuscular methotrexate in juvenile chronic arthritis. Italian Pediatric Rheumatology Study Group. , 1998, Clinical and experimental rheumatology.
[18] J. Cassidy,et al. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group. , 1992, The New England journal of medicine.
[19] R. Petty,et al. The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate. , 2004, The Journal of rheumatology.